HomeCSTL • NASDAQ
add
Castle Biosciences Inc
Previous close
$20.63
Day range
$19.86 - $20.82
Year range
$16.97 - $35.84
Market cap
573.73M USD
Avg Volume
377.32K
P/E ratio
31.89
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 86.31M | 30.54% |
Operating expense | 66.08M | 11.33% |
Net income | 9.59M | 471.71% |
Net profit margin | 11.11 | 384.87% |
Earnings per share | 0.32 | 420.00% |
EBITDA | 9.82M | 503.37% |
Effective tax rate | -21.62% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 293.13M | 20.58% |
Total assets | 531.24M | 17.18% |
Total liabilities | 75.40M | 21.47% |
Total equity | 455.84M | — |
Shares outstanding | 28.51M | — |
Price to book | 1.29 | — |
Return on assets | 1.94% | — |
Return on capital | 2.13% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 9.59M | 471.71% |
Cash from operations | 24.36M | 31.09% |
Cash from investing | 5.77M | 175.21% |
Cash from financing | -5.38M | -63.33% |
Net change in cash | 24.75M | 224.89% |
Free cash flow | 14.87M | -8.49% |
About
Founded
2007
Headquarters
Website
Employees
761
